B

Biome Australia Ltd
ASX:BIO

Watchlist Manager
Biome Australia Ltd
ASX:BIO
Watchlist
Price: 0.46 AUD 8.24% Market Closed
Market Cap: 100.9m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

BIO doesn't have a meaningful market cap.

The Relative Value of one BIO stock under the Base Case scenario is 0.27 AUD. Compared to the current market price of 0.46 AUD, Biome Australia Ltd is Overvalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIO Relative Value
Base Case
0.27 AUD
Overvaluation 42%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

6.3
P/S
P/S
Price to Sales
6.3
vs History
31
vs Industry
5
Median 3Y
0
Median 5Y
0
Industry
1
Forward
5.3
More Details
349.4
P/E
P/E
Price to Earnings
349.4
vs History
9
vs Industry
0
Median 3Y
0
Median 5Y
0
Industry
16.5
Forward
151.7
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
11.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
16.8
More Details
22.2
P/B
P/B
Price to Book Value
22.2
vs History
34
vs Industry
0
Median 3Y
7.9
Median 5Y
6.3
Industry
1.5
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
36
vs Industry
6
Median 3Y
0
Median 5Y
0
Industry
1.2
Forward
5.2
More Details
10.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.1
vs History
36
vs Industry
12
Median 3Y
0
Median 5Y
0
Industry
3.8
More Details
215.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
215.5
vs History
11
vs Industry
1
Median 3Y
0
Median 5Y
0
Industry
9.6
Forward
88.5
More Details
215.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
215.5
vs History
11
vs Industry
1
Median 3Y
0
Median 5Y
0
Industry
12.7
Forward
121.7
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
12.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
14.6
More Details
25.2
EV/IC
EV/IC
Enterprise Value to IC
25.2
vs History
50
vs Industry
1
Median 3Y
27.2
Median 5Y
24.7
Industry
1.2
More Details

Multiples Across Competitors

BIO Competitors Multiples
Biome Australia Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Biome Australia Ltd
ASX:BIO
100.8m AUD 6.3 349.4 215.5 215.5
FR
L'Oreal SA
PAR:OR
199B EUR 4.6 31 19.1 23.2
UK
Unilever PLC
LSE:ULVR
116.6B GBP 2.3 24 146.7 169.8
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.7 51.8 36.4 40
UK
HALEON PLC
LSE:HLN
37.5B GBP 3.3 26 15.3 17.2
DE
Beiersdorf AG
XETRA:BEI
26.9B EUR 2.7 29.5 12.5 15.2
US
Estee Lauder Companies Inc
NYSE:EL
24.1B USD 1.6 -27.6 13.3 21.5
JP
Kao Corp
TSE:4452
3.1T JPY 1.9 26.9 12.2 19.1
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.8 68 40.9 44.4
IN
Dabur India Ltd
NSE:DABUR
855.9B INR 6.8 48.4 36.1 44.7
CN
Giant Biogene Holding Co Ltd
HKEX:2367
73B HKD 12.1 32.5 25.9 26.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
B
Biome Australia Ltd
ASX:BIO
Average EV/EBITDA: 52.2
215.5
N/A N/A
FR
L'Oreal SA
PAR:OR
19.1
6%
3.2
UK
Unilever PLC
LSE:ULVR
146.7
3%
48.9
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
36.4
8%
4.5
UK
HALEON PLC
LSE:HLN
15.3
5%
3.1
DE
Beiersdorf AG
XETRA:BEI
12.5
2%
6.2
US
Estee Lauder Companies Inc
NYSE:EL
13.3
3%
4.4
JP
Kao Corp
TSE:4452
12.2
7%
1.7
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
40.9
14%
2.9
IN
Dabur India Ltd
NSE:DABUR
36.1
12%
3
CN
G
Giant Biogene Holding Co Ltd
HKEX:2367
25.9
26%
1

See Also

Summary
BIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIO stock valuation using valuation multiples.
Wall Street Estimates
BIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 258,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.